0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query qyresearch global cardiomyopathy devices market research report 2016.Your search for "" gave back 1533064 results.
Dilated cardiomyopathy (DCM) is a condition in which the heart's ability to pump blood is decreased because the heart's main pumping...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Dilated Cardiomyopathy (DCM) is a condition in which heart's left ventricle, is enlarged and weakened and the ability to pump blood is decreased...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Summary Publisher estimates that the Cardiomyopathy Devices market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with...
Catalog:
HYR
June 2021
Price: USD 2,000.00
Summary The Cardiomyopathy Devices market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base...
Catalog:
HYR
February 2021
Price: USD 2,000.00
Ventricular Tachycardia (Cardiovascular) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
August 2021
Price: USD 2,000.00
Ventricular Tachycardia - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
October 2020
Price: USD 2,000.00
Ventricular Tachycardia - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
April 2020
Price: USD 2,000.00
Frataxin Mitochondrial - Pipeline Review, H2 2019 Summary Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Frataxin is a...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Ventricular Tachycardia - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
The global Total Artificial Heart market size was valued at USD 40 million in 2023 and is forecast to a readjusted size of USD 150.3 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) Drugs in Development by Therapy Areas...
Catalog:
Global Markets Direct
June 2022
Price: USD 3,500.00
High Mobility Group Protein B1 - Drugs In Development, 2021 Summary According to the recently published report 'High Mobility Group Protein B1...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
Frataxin Mitochondrial - Pipeline Review, H1 2020 Summary Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) pipeline Target...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Hypertrophic Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets...
Catalog:
Global Markets Direct
August 2022
Price: USD 2,000.00
